Now, keep up to date
with daily feeds of newly posted stories
about America's Seniors...click on the box
to the left
Mammograms: Detecting more than Breast
Cancer, may help assess heart risk in Kidney
Disease Patients
Newswise,
January 26, 2011 — Routine mammograms
performed for breast cancer screening could
serve another purpose as well: detecting
calcifications in the blood vessels of
patients with advanced kidney disease,
according to a study appearing in an
upcoming issue of the Clinical Journal of
the American Society of Nephrology (CJASN).
Mammograms show calcium deposits in the
breast arteries in nearly two-thirds of
women with end-stage renal disease (ESRD),
according to the study by W. Charles
O'Neill, MD (Emory University, Atlanta).
"Breast arterial calcification is a specific
and useful marker of medial vascular
calcification in chronic kidney disease
(CKD), and its prevalence is markedly
increased in ESRD and advanced CKD," the
researchers write.
Arterial calcium deposits may contribute to
the high rate of death from heart disease in
patients with CKD and ESRD. In addition to
calcifications of the inner or "intimal"
layer of the blood vessels
(atherosclerosis), calcifications can also
occur in the middle, or "medial" layer.
These medial calcium deposits may contribute
to cardiovascular disease risk by making the
arteries stiffer, but they can be difficult
to detect./b>
In an initial study, Dr. O'Neill and
colleagues examined samples of breast artery
tissue from 16 women with kidney disease.
While all of the samples showed medial
calcifications of the breast artery, none
showed intimal calcifications.
When the researchers reviewed routine
mammograms performed in 71 women with ESRD,
they found breast arterial calcifications in
63 percent of patients. In contrast, in a
matched group of women without kidney
disease, mammograms showed breast arterial
calcifications in just 17 percent of cases.
Thirty-six percent of the women with kidney
disease already had breast arterial
calcifications on mammograms performed
several years earlier—before their kidney
disease advanced to ESRD. More than 90
percent of women with calcifications of the
breast artery also had evidence of medical
calcifications in other blood vessels.
Calcium deposits seen on mammograms could be
"a marker of generalized medical vascular
calcifications" in patients with kidney
disease, the researchers write. The results
support the theory that CKD predisposes to
medial calcification, which may in turn,
contribute to cardiovascular disease.
Since most women with CKD are at an age
where yearly mammograms are recommended,
mammograms may be a useful tool for studying
the development and progression of medical
calcifications.
O'Neill and colleagues call
for further studies of arterial calcium
deposits in patients with kidney
disease—including whether early
identification and treatment might help to
lower the associated risk of cardiovascular
disease.
The study had some important limitations,
including the relatively small number of
patients studied.
The authors report no financial disclosures.
The article, entitled “Breast Arterial
Calcification: A Marker of Medial Vascular
Calcification in Chronic Kidney Disease,” (doi
10.2215/CJN.07190810), will appear online at
http://cjasn.asnjournals.org/ on
January 20, 2011.
The American Society of Nephrology (ASN)
does not offer medical advice. All content
in ASN publications is for informational
purposes only, and is not intended to cover
all possible uses, directions, precautions,
drug interactions, or adverse effects.
This content should not be used during a
medical emergency or for the diagnosis or
treatment of any medical condition.
Please consult your doctor or other
qualified health care provider if you have
any questions about a medical condition, or
before taking any drug, changing your diet
or commencing or discontinuing any course of
treatment.
Do not ignore or delay obtaining
professional medical advice because of
information accessed through ASN. Call 911
or your doctor for all medical emergencies.
Founded in 1966 and comprised of more than
12,000 members, the American Society of
Nephrology (ASN) leads the fight against
kidney disease by educating health
professionals, sharing new knowledge,
advancing research, and advocating the
highest quality care for patients.